Caricamento...
INHALED ALPHA(1)-PROTEINASE INHIBITOR THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
BACKGROUND: Inhaled alpha(1)-proteinase inhibitor (PI) is known to reduce neutrophil elastase burden in some patients with CF. This phase 2a study was designed to test inhaled Alpha-1 HC, a new aerosolized alpha(1)-PI formulation, in CF patients. METHODS: We performed a randomized, double-blind, pla...
Salvato in:
| Pubblicato in: | J Cyst Fibros |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4993024/ https://ncbi.nlm.nih.gov/pubmed/26321218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2015.07.009 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|